Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET
Recruiting
Phase 3
Interventional Study
Subfertility
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 42
- Sex
- Female
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 716 (estimated)
- Sponsor
- The University of Hong Kong · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This randomised double-blinded controlled trial aims to compare the live birth rate in natural FET cycles with and without oral dydrogesterone as luteal phase support. The hypothesis is that the use of oral dydrogesterone will increase the live birth rate of natural cycle FET.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age of women \<43 years at the time of stimulated IVF
* Replacing early cleavage embryos or blastocysts after thawing
Exclusion Criteria:
* Requiring hormonal replacement cycles
* Use of donor oocytes or embryos
* Undergoing preimplantation genetic testing
* Presence of hydr…
Contacts